Clinical Trial Update: Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary activity of sorafenib tosylate in combination with cisplatin and docetaxel for patients with recurrent or me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Docetaxel (Taxotere) (docetaxel)
• Sorafenib tosylate (Nexavar) (sorafenib)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Phase 1 | Status: COMPLETED